Skepticism Rises Over Plasma as COVID-19 Treatment
People who were hoping plasma may be the answer to curing COVID-19 may be in…
Category: Medicine
More Recalls Due to Salmonella: Shrimp, Peaches
If you’ve bought peaches or shrimp lately, check to see if they’ve been recalled because…
STAT Plus: Pharmalittle: FDA official would resign if agency pressured to OK Covid-19 vaccine; J&J plans huge vaccine trial
And so, another working week will soon draw to a close. Not a moment too…
Opinion: The Trump administration’s ‘public charge’ rule and Covid-19: bad policy at the worst time
As Covid-19 sweeps across the country, many immigrant communities are being hit hard by the…
Opinion: Infections acquired in health facilities are a big problem. National reporting can help fix it
Contagious diseases are as old as time and routinely appear in health care settings. New…
STAT Plus: Biomarin, Gilead drug rejections don’t signal a change in attitude at the FDA
It’s tempting to interpret the Food and Drug Administration’s surprise rejections of drugs from Gilead…
.jpg)
‘No miracle is coming’: In acceptance speech, Biden rips Trump for Covid-19 mismanagement
WASHINGTON — Former vice president Joe Biden excoriated President Trump’s Covid-19 response as he accepted…
Listen: Shocking FDA rejections, a setback in longevity science, & the latest on Covid-19 immunity
Did the FDA suddenly get stringent about new drugs? Is longevity research over-hyped? And what…
Troubles Remain for OxyContin Producer Purdue, 49 States Suing
Purdue, which marketed OxyContin, is still in trouble as 49 states file for $2.2 trillion…
STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
A growing number of drug makers are taking steps to curtail the discounts they offer…
When Planes Not Full, COVID Risk Drops
Flying during the pandemic is risky, but the risk drops when planes aren’t at full…
COVID-19: The Need, Encore, to Separate Fact from Fiction
If you think that ingesting a poisonous plant that hasn’t been put through the rigors…
.jpg)
Wary hemophilia patients say they’re willing to wait longer for a safe gene therapy
The Food and Drug Administration’s rejection of a gene therapy for hemophilia A on Wednesday…
Grandma Was Right, Honey Good for Treating Coughs and Colds
Have a cough or cold? Reach into your pantry for honey before trying OTC cold…
STAT Plus: Boehringer to pay $379,000 to settle charges of wage discrimination against female employees
Following a review by the Department of Labor, a unit of Boehringer Ingelheim agreed to…
Pfizer and BioNTech’s favored Covid-19 vaccine has fewer side effects than their first
Pfizer and BioNTech surprised many industry watchers on July 27 when they announced they would…
Dog Bites Dropping, But Good Training – of Humans and Dogs – Still Vital
Teach children how to act – and not act – around dogs. The number of…
STAT Plus: Pharmalittle: Mail slowdown could limit access to drugs; CureVac nears a Covid-19 vaccine deal with Europe
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
Covid-19 test accuracy supplement: The math of Bayes’ Theorem
Example 1: Low pre-test probability (asymptomatic patients in Massachusetts) First, we need to estimate the…
Opinion: Even Covid-19 tests that aren’t perfect can help control the pandemic
A key component to managing the Covid-19 pandemic is frequent, rapid, and routine testing of…
As Covid-19 cases in prisons climb, data on race remain largely obscured
By mid-August, jails, prisons, and other detention centers accounted for all of the top 10…
STAT Plus: Stunning FDA rejection signals potential new hurdles for gene therapies
The Food and Drug Administration’s unexpected rejection of a gene therapy for the bleeding disorder…
Ramped-up testing and daily briefings: Inside Biden’s plan to take over a tumultuous Covid-19 response
WASHINGTON — No president has ever inherited a pandemic. But if Joe Biden is elected…
STAT Plus: Otsuka approved to buy bankrupt smart-pill maker Proteus’ assets, overcoming effort by Novartis to block purchase
The Japanese drug maker Otsuka has been approved to purchase the assets of bankrupt smart…
More Colleges Close After Re-Opening
In-person classes, online classes, hybrids – colleges are forced to rethink original plans as infection…
Onions in Your Pantry? Check Them for Salmonella Recall
Onions don’t usually carry salmonella, but the FDA had to recall onions distributed by Thomson…
Kids Can Still Eat Before HbA1c Test Screening for Prediabetes
New guidelines suggest more children should be tested for prediabetes. It may be easier to…
STAT Plus: After FDA rejection of a key drug, is Gilead still a turnaround story?
The surprise decision by the FDA to reject a Gilead Sciences (GILD) drug for treating…
New research tabs a natural byproduct of metabolism as a potent trigger of cancer spread
Aging is the biggest risk factor for cancer: The older we get, the more likely…
STAT Health Tech: How Teladoc won and Lyft’s Medicaid transportation business
A version of this digest first appeared in the weekly STAT Health Tech newsletter. To…
A Beginner’s Breakdown: Why and How Does CBD Work?
From oils and tinctures to gummies and lotions, the numerous varieties of CBD products available…
STAT Plus: Pharmalittle: FDA surprises BioMarin and Gilead by rejecting key drugs; J&J pays $6.5 billion to buy Momenta
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Double Duty: Protecting Your Heart May Decrease Dementia Risk
We know that protecting our heart is an important part of healthy living. But by…
STAT Plus: Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing
Turning Point Therapeutics, a San Diego developer of targeted cancer drugs, released positive data Wednesday…
STAT Plus: In a shocking decision, FDA rejects BioMarin’s gene therapy for hemophilia
The Food and Drug Administration on Wednesday rejected a one-time therapy for hemophilia A, delaying…
STAT Plus: J&J to buy Momenta Pharma in a bid to bolster autoimmune disease pipeline
Health care giant Johnson & Johnson said Wednesday that it is acquiring Momenta Pharmaceuticals, gaining…
STAT Plus: An expected blockbuster drug from Gilead is rejected, imperiling the biotech’s future growth
Back before remdesivir became a household name, Gilead Sciences’ most-discussed drug was filgotinib, a treatment…
Opinion: It’s time to stop using skin color and race in medicine and see patients for who they really are
My parents fell in love at a time when their union was illegal in 16…
Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking
As potential Covid-19 vaccines speed their way through development, manufacturers and U.S. regulators have largely…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
STAT Plus: FDA finalizes penalties for trial sponsors that don’t share data, but critics say the effort falls short
After a year of deliberation, the Food and Drug Administration released final guidelines for penalizing…
Full-Body Checks for Seniors Help Detect Skin Conditions
There’s no need to live with the discomfort of many skin conditions. All seniors should…
STAT China: A debut for CanSino Biologics and Cellular BioMed’s controversy
A version of this digest first appeared in the weekly STAT China newsletter. To receive…
Virtual Event: AI: Cracking Covid-19’s Code
Editor’s note: A live stream of this virtual event will be embedded above at 1…
STAT Plus: Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
LGBTQ youth say cost, parental permission pose major barriers to mental health care
The Covid-19 pandemic stands to exacerbate the existing mental health crisis among LGBTQ youth, who…
Trump campaign’s Facebook ad blitz casts Biden as pharma’s preferred candidate
WASHINGTON — President Trump’s reelection campaign is appealing to swing voters by attacking “Big Pharma”…
Opinion: ICU capacity is more about the clinicians than the number of beds
Each time communities experience surges of Covid-19, concerns arise over the availability of hospital and…
STAT Plus: How Teladoc won: The inside story of how well-timed bets propelled it ahead of the competition
The unquestioned leader in a virtual care sector that has surged in the Covid-19 era,…
How do you separate scientifically sound stem cell therapies from scams?
For patients who’ve run out of other options, experimental, unproven therapies like stem cell treatments…